Pharma Industries News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Percent. Shanghai stocks down by close to 1 a decline of more than nine tenths in europe there have been some green arrows the dax is up by. 2 the cac is up by a quarter percentage points. Stocks up in italy, spain and london crude oil prices which ended last week just shy of 59 a barrel, check this out right now, down by about 44 cents. Still, wti trading above 58 at 58. 51 a barrel. Now this morning the big news of the day. Publisher meredith buying time, inc. , for2. 8 billion thats the price meredith will pay 18. 50 for time, inc. It publishes wellknown magazines such as time, peopl people...

[ is distinct conversations ]. And live here this morning on c spann span 3, a discussion about transparency and oversight at the food and Drug Administration. Well be hearing from dr. Scott gottlieb starting off the conference. Introductions under way. Efforts to pass and implement the food safety modernization act, focus on medical devices, especially the potential of using the unique device identifier to improve monitoring devices throughout the product lifecycle. We have successfully worked on products 10 to courage innovation particularly around antibiotics and 10 to sure appropriate use ...

Investors. During this portion of the event we hear from jonathan left, chair of the deerfield institute. Its 25 minutes. Thank you so much for coming. Chairman of the deerfield institute, he joined this company in 2013. The company focuses on Venture Capital and structured investments and Bio Technology and pharmaceuticals. Prior for 16 years he led the firms in investment in Bio Technology and pharmaceuticals. Hes been active in policy discussions, served on the executive committee on the board of national Venture Capital association and led that groups Life Sciences efforts. Hes also served...

The company focuses on Venture Capital and structured investments and Bio Technology and pharmaceuticals. Prior for 16 years he led the firms in investment in Bio Technology and pharmaceuticals. Hes been active in policy discussions, served on the executive committee on the board of national Venture Capital association and led that groups Life Sciences efforts. Hes also served on the emerging Company Section board on the Bio Technology board industry organization. Hes served on many nonprofit boards. He is a graduate of Harvard University and the Stanford School of business. And we really appr...

The research focuses on the intersection of technology, policy, business losses wider ramifications of key technological trends and development. He testified before congress more recently on drums, privacy and intellectual property and also the broad for the Global Agenda Council and cybersecurity. John is going to go through the basics of sections of a note to and sort of like a onetoone introduction and for the rest of our program today. John, welcome good thank you for coming today. I realize theres probably some countrys top experts on seven of two of the room and perhaps people who know a...